NORWALK, CT–(Marketwire – October 30, 2009) – Elsevier Business Intelligence and Windhover
Conferences have announced their complete Top 10 Projects to Watch for the
upcoming Therapeutic Area Partnerships event, Nov. 17-19 in Boston, MA.
This year’s list will offer a Top 10 in each of four therapeutic areas:
cardiovascular/metabolic, oncology, neuroscience and
inflammatory/autoimmune. Past Windhover top 10 candidates signed a total
potential value of $17 billion US in acquisitions and alliances. Confirmed
participating companies include Lundbeck, Astellas, Biovail, Bristol-Myers
Squibb, Biogen Idec, Millennim, Merck, Novartis, Eli Lilly, Genzyme, Merck
and Company, Wyeth, GlaxoSmithKline, Merck Serono, Daiichi Sankyo, and
AstraZeneca.